✧Physical Protection
The bilayer shields the active from gastric acid, digestive enzymes and oxygen until it reaches the absorption site.
OriginBio takes you from the botanical raw material to the finished bottle. In-house extraction combined with a nanoencapsulation platform: ≤ 200 nm particle size, TEM imaging and third-party testing with every batch, 1 kg MOQ and full OEM / ODM dosage-form development.



Liposomes are spherical vesicles (typically ≤ 200 nm) formed from phospholipid bilayers, structurally similar to human cell membranes. Water-soluble actives are trapped in the aqueous core, while fat-soluble actives sit inside the lipid bilayer.
This encapsulation protects sensitive compounds from oxidation, stomach acid and enzymes, masks bitter taste, and has been shown in published studies to improve absorption compared with non-encapsulated forms:

The bilayer shields the active from gastric acid, digestive enzymes and oxygen until it reaches the absorption site.
Phospholipid membranes resemble intestinal epithelial membranes, allowing direct fusion and endocytosis that bypasses some active-transport bottlenecks.
Our liposomal delivery platform uses phospholipid bilayers to protect active ingredients, supporting improved dispersion and absorption and potentially enhancing bioavailability and blood concentrations.
Our liposomal ingredients are built for manufacturers, brand owners and formulators:

Higher bioavailability claims, smaller dose per serving.

Water-dispersible actives that don't settle, with masked bitterness and protection during heat processing.

Fast-absorbing formats for premium positioning in energy, recovery and anti-aging products.

Palatable, low-dose actives for chews and liquids that support joint and immune health.

Better skin penetration, oxidation-sensitive actives kept stable, and a clean-label 'liposome' story.



| Test Item | Method / Equipment | Specification |
|---|---|---|
| Particle size & PDI | Dynamic Light Scattering (Malvern Zetasizer) | ≤ 200 nm, PDI ≤ 0.3 |
| Zeta potential | Electrophoretic light scattering | ≤ -30 mV (stable) |
| Morphology | Transmission Electron Microscopy (TEM) | Spherical bilayer vesicles |
| Heavy metals | ICP-MS (USP <231>) | Pb ≤ 1 ppm, As ≤ 1 ppm, Cd ≤ 1 ppm, Hg ≤ 0.1 ppm |
| Microbiology | USP <2021>/<2022> | TPC ≤ 1000 cfu/g, Pathogens negative |
| Residual solvents | GC (ICH Q3C) | Complies |

HPMC (vegan) or gelatin capsules, size 00-5. Liposomal powder fill with enteric or delayed-release options.

Ideal for liposomal CoQ10, curcumin and fat-soluble actives. HPMC or Gelatin capsules.

Liposomal glutathione or NMN in sachets, stick packs or tubs. Water-dispersible, flavor-masked.

Liposomal quercetin, glutathione, berberine HCI, vitamin C or other active ingredients in liquid sachets or stick packs. Ready-to-drink, easy to consume, and formulated for convenient daily use.

A Singapore-based nutrition and health company planned to develop a liposomal NAD+ liquid product to enhance market competitiveness through a higher active ingredient content. However, the client was unsure whether to choose a 50% or 70% specification and needed a stable, scalable liquid formulation. Higher loading levels may compromise encapsulation efficiency and storage stability. NAD+ is also sensitive to temperature, pH, and light, while liquid formulations present additional challenges related to sedimentation, oxidation, and microbial control.
OriginBio evaluated raw material specifications, film formation, homogenization, filtration, quality control, and market requirements. We recommended the 50% specification and proposed an integrated formulation strategy covering pH control, suspension stability, oxidation protection, and preservation, with key validation parameters including particle size, PDI, and encapsulation efficiency.
Based on our recommendations, the client purchased our validated 50% liposomal NAD+ liquid formulation and successfully developed a related product that gained market acceptance.
Every batch is tested for particle size and PDI (dynamic light scattering), zeta potential, encapsulation efficiency (HPLC after ultrafiltration separation), morphology (TEM imaging), heavy metals, microbiology and residual solvents. A full COA accompanies each shipment.
Every batch ships with third-party Cryo-TEM imaging showing an intact bilayer vesicle structure, plus a dynamic light scattering (DLS) particle size distribution report. Encapsulation efficiency (EE%) is measured after physically separating free actives by ultrafiltration or gel chromatography - not estimated from the lecithin input. Each COA states D50, PDI, zeta potential and EE%.
Non-GMO sunflower lecithin (allergen-free) is standard; non-GMO soy phosphatidylcholine is available on request.
Standard MOQ is 1 kg for samples and 25 kg for bulk. Stock products ship within 3-5 working days; custom formulations take 3-4 weeks including pilot testing.
Yes. We supply finished powdered beverage, softgels, capsules and gummies with liposomal actives, incuding formula development, stability testing and label compliance support for US/EU markets.
24 months in sealed aluminum foil bags stored below 25°C, supported by real-time and accelerated stability data (CH Q1A conditions).
Interested in our supplements? Get your personalized quote now!
Call us on:
Email Us:
Office Add: